Syndax Pharmaceuticals (SNDX) PT Lowered to $51 at Goldman Sachs

May 9, 2022 11:03 PM EDT Send to a Friend

Goldman Sachs analyst Madhu Kumar ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Syndax Pharmaceuticals (SNDX) PT Lowered to $51 at Goldman Sachs

Member Login

Free News Feed